This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
Mark Your Calendar for BPI Europe 2025
12-15 May 2025Congress Center Hamburg, Germany

Joey Studts, Ph.D.
Director, Late Stage Purification Development at Boehringer Ingelheim Pharma GmbH & Co. KG


Dr. Joey Studts is currently Director of Downstream Development in the Innovation Unit of Boehringer Ingelheim Pharma GmbH in Biberach Germany. In this role, he is responsible for the development of purification processes for the production of therapeutic proteins for pre-clinical, clinical, and market supply. Dr. Studts has a strong focus on late-stage process development with experience in bringing innovative drugs to the market from a CMC perspective as well as implementing novel technologies in the fields of modeling, digital control strategies and PAT. Dr. Studts did a post-doctoral fellowship in the Department of Immunology at Washington University in St. Louis with Professor Daved Fremont, Ph.D. Joey received his Ph.D. under the guidance of Professor Brian G. Fox, Ph.D., at the Institute for Enzyme Research in the Department of Biochemistry at the University of Wisconsin at Madison after completing a B.S. in Chemistry at Loras College in Dubuque, IA, USA.

Agenda Sessions

  • Application of Modelling Tech in BLA